Wencke Walter

4.1k total citations · 1 hit paper
85 papers, 2.1k citations indexed

About

Wencke Walter is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Wencke Walter has authored 85 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Hematology, 26 papers in Genetics and 25 papers in Molecular Biology. Recurrent topics in Wencke Walter's work include Acute Myeloid Leukemia Research (46 papers), Cancer Genomics and Diagnostics (20 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers). Wencke Walter is often cited by papers focused on Acute Myeloid Leukemia Research (46 papers), Cancer Genomics and Diagnostics (20 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers). Wencke Walter collaborates with scholars based in Germany, United States and Spain. Wencke Walter's co-authors include Mercedes Ricote, Fátima Sánchez‐Cabo, Torsten Haferlach, Claudia Haferlach, Wolfgang Kern, Manja Meggendorfer, Stephan Hütter, Niroshan Nadarajah, Constance Baer and Anna Stengel and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Bioinformatics.

In The Last Decade

Wencke Walter

66 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

GOplot: an R package for visually combining expression data with functional analysis

2015 1.2k citations Wencke Walter, Fátima Sánchez‐Cabo et al. profile →

Peers

Countries citing papers authored by Wencke Walter

Since Specialization

Citations

This map shows the geographic impact of Wencke Walter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wencke Walter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wencke Walter more than expected).

Fields of papers citing papers by Wencke Walter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wencke Walter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wencke Walter. The network helps show where Wencke Walter may publish in the future.

Co-authorship network of co-authors of Wencke Walter

This figure shows the co-authorship network connecting the top 25 collaborators of Wencke Walter. A scholar is included among the top collaborators of Wencke Walter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wencke Walter. Wencke Walter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Distinct characteristics of VEXAS-causative UBA1 M41 and recurrent functional non-M41 mutations 2025 ·Leukemia ·Maki Sakuma, (unknown), (unknown), (unknown), Manja Meggendorfer, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach, David B. Beck, Wencke Walter	0
2	A lineage-specific STAT5B N642H mouse model to study NK-cell leukemia 2024 ·Blood ·Klara R. Klein, (unknown), (unknown), (unknown), (unknown), Thorsten Klampfl, (unknown), Jana Trifinopoulos, Barbara Maurer, Reinhard Grausenburger, (unknown), Richard Moriggl, Thomas Rülicke, Charles G. Mullighan, Agnieszka Witalisz‐Siepracka, Wencke Walter, Gregor Hoermann, Veronika Sexl, Dagmar Gotthardt	4
3	UBA1 dysfunction in VEXAS and cancer 2024 ·Oncotarget ·Maki Sakuma, (unknown), Wencke Walter	4
4	Phenotypic and Genetic Heterogeneity of NPM1 Mutated AML at Diagnosis and during Course of Disease 2024 ·Blood ·Veronika Ecker, Sandra Huber, Wencke Walter, Stephan Hütter, (unknown), Manja Meggendorfer, Constance Baer, Claudia Haferlach, Torsten Haferlach, Wolfgang Kern	0
5	Proximally biased V(D)J recombination in the clonal evolution of IGH alleles in KMT2A::AFF1 BCP‐ALL of all age classes 2024 ·HemaSphere ·Heiko Müller, Frank Dicker, (unknown), Wencke Walter, Stephan Hütter, Niroshan Nadarajah, Manja Meggendorfer, Qingsong Gao, Ilaria Iacobucci, Charles G. Mullighan, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach	0
6	Collaborative effect of Csnk1a1 haploinsufficiency and mutant p53 in Myc induction can promote leukemic transformation 2023 ·Blood Advances ·(unknown), (unknown), Inge Snoeren, Eric M. Bindels, Stephani Schmitz, (unknown), Remco M. Hoogenboezem, (unknown), Mohamed I. Saad, Wencke Walter, Torsten Haferlach, (unknown), Julio Sáez-Rodríguez, Aurélien Dugourd, Kjong-Van Lehmann, Yinon Ben‐Neriah, Hélène F.E. Gleitz, Rebekka K. Schneider	0
7	Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022 2023 ·Blood ·Francis Baumgartner, Constance Baer, Stefanos A. Bamopoulos, Edward Ayoub, Marietta Truger, Manja Meggendorfer, Miriam Lenk, Gregor Hoermann, Stephan Hütter, Heiko Müller, Wencke Walter, (unknown), Niroshan Nadarajah, Piers Blombery, Ulrich Keller, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach	10
8	Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q 2022 ·EBioMedicine ·Vera Ademà, Laura Palomo, Wencke Walter, Mar Mallo, Stephan Hütter, (unknown), Leonor Arenillas, Manja Meggendorfer, Tomas Radivoyevitch, Blanca Xicoy, Andrea Pellagatti, Claudia Haferlach, Jacqueline Boultwood, Wolfgang Kern, Valeria Visconte, Mikkael A. Sekeres, John Barnard, Torsten Haferlach, Françesc Solé, Jaroslaw P. Maciejewski	11
9	Whole Genome Sequencing Identifies Non-KIT Mutations and Cytogenetic Aberrations in Systemic Mastocytosis but Has Limited Sensitivity for Detection of KIT D816V 2021 ·Blood ·Gregor Hoermann, Manja Meggendorfer, Constance Baer, Heiko Müller, Wencke Walter, Stephan Hütter, Christian Pohlkamp, Niroshan Nadarajah, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach	0
10	Benchmarking of Whole Genome Sequencing (WGS) and Whole Transcriptome Sequencing (WTS) As Diagnostic Tools for the Genetic Characterization of Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL) in Adults 2021 ·Blood ·Claudia Haferlach, Wencke Walter, Manja Meggendorfer, Anna Stengel, Constance Baer, Stephan Hütter, Niroshan Nadarajah, Heiko Müller, Wolfgang Kern, Torsten Haferlach	2
11	Maturation State-Specific Alternative Splicing in FLT3-ITD and NPM1 Mutated AML 2021 ·Cancers ·Anna Wojtuszkiewicz, Inge van der Werf, Stephan Hütter, Wencke Walter, Constance Baer, Wolfgang Kern, Jeroen J. W. M. Janssen, Gert J. Ossenkoppele, Claudia Haferlach, Jacqueline Cloos, Torsten Haferlach	4
12	Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia 2021 ·Leukemia ·Sunisa Kongkiatkamon, Simona Pagliuca, Vera Ademà, Yasunobu Nagata, Cassandra M Kerr, Wencke Walter, Hassan Awada, Stephan Hütter, Carmelo Gurnari, Heesun J. Rogers, Manja Meggendorfer, Yogen Saunthararajah, Torsten Haferlach, Valeria Visconte, Jaroslaw P. Maciejewski	3
13	SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia 2021 ·Leukemia ·Inge van der Werf, Anna Wojtuszkiewicz, Huilan Yao, Rocco Sciarrillo, Manja Meggendorfer, Stephan Hütter, Wencke Walter, Jeroen J. W. M. Janssen, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach, Gerrit Jansen, Gertjan J.L. Kaspers, Richard W.J. Groen, Gert J. Ossenkoppele, Jacqueline Cloos	8
14	Complex landscape of alternative splicing in myeloid neoplasms 2020 ·Leukemia ·Courtney E. Hershberger, (unknown), Vera Ademà, Cassandra M Kerr, Wencke Walter, Stephan Hütter, Manja Meggendorfer, Constance Baer, Wolfgang Kern, Niroshan Nadarajah, Sven Twardziok, Mikkael A. Sekeres, Claudia Haferlach, Torsten Haferlach, Jaroslaw P. Maciejewski, Richard A. Padgett	37
15	Genotype-Phenotype Correlations in Patients with Myeloid Malignancies Using Explainable Artificial Intelligence 2020 ·Blood ·Nathan Radakovich, Luca Malcovati, Manja Meggendorfer, Mikkael A. Sekeres, Jacob Shreve, (unknown), (unknown), Wencke Walter, Stephan Hütter, Anna Gallì, Sarah Pozzi, Aaron T. Gerds, Sudipto Mukherjee, Cassandra M Kerr, Babal K. Jha, Claudia Haferlach, Jaroslaw P. Maciejewski, Torsten Haferlach, Aziz Nazha	2
16	A Personalized Prediction Model to Risk Stratify Patients with Acute Myeloid Leukemia (AML) Using Artificial Intelligence 2019 ·Blood ·Jacob Shreve, Manja Meggendorfer, Hassan Awada, Sudipto Mukherjee, Wencke Walter, Stephan Hütter, (unknown), (unknown), Nathan Radakovich, Yasunobu Nagata, (unknown), Vera Ademà, Cassandra M Kerr, Bhumika J. Patel, Teodora Kuzmanovic, Jaroslaw P. Maciejewski, Claudia Haferlach, Mikkael A. Sekeres, Torsten Haferlach, Aziz Nazha	15
17	“Somatic” and “pathogenic” - is the classification strategy applicable in times of large-scale sequencing? 2019 ·Haematologica ·Constance Baer, Wencke Walter, Stephan Hütter, Sven Twardziok, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach	8
18	Deciphering the Dynamic Transcriptional and Post-transcriptional Networks of Macrophages in the Healthy Heart and after Myocardial Injury 2018 ·Cell Reports ·Wencke Walter, Laura Alonso-Herranz, Verdiana Trappetti, Isaac Crespo, Mark Ibberson, Marta Cedenilla, (unknown), Vanessa Núñez, Ioannis Xénarios, Alicia G. Arroyo, Fátima Sánchez‐Cabo, Mercedes Ricote	48
19	Phagocytosis imprints heterogeneity in tissue-resident macrophages 2017 ·The Journal of Experimental Medicine ·Noelia A-González, Juan A. Quintana, Susana García‐Silva, Marina S. Mazariegos, (unknown), José Ángel Nicolás-Avila, Wencke Walter, José M. Adrover, Georgiana Crainiciuc, Vijay K. Kuchroo, Carla V. Rothlin, Héctor Peinado, Antonio Castrillo, Mercedes Ricote, Andrés Hidalgo	201
20	Deep Learning Algorithms Support Distinction of PV, PMF, and ET Based on Clinical and Genetic Markers 2017 ·Blood ·Manja Meggendorfer, Wencke Walter, Claudia Haferlach, Wolfgang Kern, Torsten Haferlach	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact